Categories: News

Vital Data Technology Expands Affinitē Risk Adjustment into a Complete End-to-End Solution

NEWPORT BEACH, Calif., June 2, 2021 /PRNewswire/ — Vital Data Technology, a data science-driven healthcare solutions leader, today announced the expansion of their Affinitē Risk Adjustment (RA) solution. With additional capabilities, Affinitē RA is a complete risk adjustment solution with suspect logic to ensure an accurate assessment of risk scores, giving payers a complete financial picture of their population.

“We’re spending more on healthcare than ever and the COVID-19 pandemic just accelerated the need for rapid innovation,” commented Matt D’Ambrosia, President and CEO of Vital Data Technology. “Plans need to reduce costs and provider abrasion as much as possible, but a lot of existing solutions are delivering less return on investment as the needs of the market continue to ramp up. We wanted to enhance the capabilities of Affinitē Risk Adjustment so payers get a true end-to-end solution with advanced analytics.”

Affinitē RA has embedded real-time advanced analytics that enable the plan to identify those records with the most potential to improve risk score opportunities and streamline the chart retrieval, coding, and encounters submission process. The real-time reporting package gives payers the visibility and insight needed to prioritize their prospective interventions and project mid-year and final risk scores.

“Existing solutions support the operational, transactional aspects of risk adjustment such as chart retrieval and coding. Affinitē RA, on the other hand, streamlines processes to free up risk adjustment teams to focus on strategic priorities,” explained Peter Janelle, Director of Risk Adjustment for Vital Data Technology. “Eliminating much of the time-consuming manual input, gap analysis, remediation, and provider outreach is key to allocating resources that can improve risk scores and go beyond just maintaining them.”

Affinitē Risk Adjustment is a segment of the Affinitē Platform, alongside Affinitē Quality Improvement and Care Management. By lowering the barriers between risk, quality, and care management, payers can utilize quality and care gap insights for advanced risk assessment. With an integrated data structure involving other lines of business, Affinitē RA provides increased interoperability that payers need today to execute in-house risk adjustment and deliver higher returns on investment.

For more information on Affinitē Risk Adjustment, click here or reach out directly to info@vitaldatatechnology.com.

About Vital Data Technology

Vital Data Technology is transforming the healthcare ecosystem by empowering healthcare stakeholders with prescriptive insights to improve member health and lower costs. Vital Data Technology leverages embedded, real-time data science, Ai, and analytics together to drive intelligent automation through their cloud-based Affinitē platform. Affinitē connects all data sources to align quality, risk, utilization management, and care management solutions and acts as a single source of truth for all healthcare information. With Affinitē as a single source of truth, all healthcare parties can coordinate more efficient care interventions with a true 360-degree view of the member. For more information, go to www.vitaldatatech.com, contact them via email, or follow them on LinkedIn.

Media Contact:
Jerrica Sibley
Vital Data Technology, Marketing & Communications
(866) 482-8399 x 719
311202@email4pr.com
www.vitaldatatech.com 

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/vital-data-technology-expands-affinit-risk-adjustment-into-a-complete-end-to-end-solution-301303876.html

SOURCE Vital Data Technology

Staff

Recent Posts

HMNC Brain Health Completes Patient Randomization for Phase 2b OLIVE Trial for Major Depressive Disorder

Study Marks Milestone in Precision Psychiatry for Stress-Axis-Related DepressionMUNICH, Jan. 10, 2025 (GLOBE NEWSWIRE) --…

36 minutes ago

Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates

- Signals Start of New Commercialization Phase for LineaRx Subsidiary -- Company Negotiating GMP Supply…

36 minutes ago

The Ultimate Credentialing Solution for Independent Practitioners: Transform Your Practice in 2025 With CredyApp Solo

"Solo practitioners face unique challenges in managing their credentialing needs," says Olga Khabinskay, Director of…

36 minutes ago

Disc Medicine Highlights Recent Achievements Across Hematology Portfolio and Key Business Objectives and Milestones for 2025

In Q1 2025, the Company will discuss the plans for NDA submission under a potential…

36 minutes ago

ADARx Pharmaceuticals to Present at the J.P. Morgan 43ʳᵈ Annual Healthcare Conference

SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical…

37 minutes ago